Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under InMed Pharmaceuticals Inc. in our court records and SEC 8-K records (as of 2026-10-18).
- Layoffs: 1 exit or restructuring plan reported on Form 8-K, Item 2.05 (latest filed 2026-03-06).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Adar1 Capital Management, LLC (filed 2026-10-07).
Who is behind it
InMed Pharmaceuticals Inc.: industry Pharmaceutical Preparations (Schedule 13G/A, 2026-10-07).
Officers and directors, each with the role and the filing that names them:
- Eric A. Adams: Executive Officer, Director (Form D, 2022-12-06)
- Sarah Li: Executive Officer (Form D, 2022-12-06)
- Alexandra D.J. Mancini: Executive Officer (Form D, 2022-12-06)
- Michael Woudenberg: Executive Officer (Form D, 2022-12-06)
- William J. Garner: Director (Form D, 2022-12-06)
- Janet Grove: Director (Form D, 2022-12-06)
- Andrew Hull: Director (Form D, 2022-12-06)
- Bryan Baldasare: Director (Form D, 2022-12-06)
- Nicole Lemerond: Director (Form D, 2022-12-06)
- Eric C. Hsu: Executive Officer (Form D, 2022-12-06)
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-10-07 | Adar1 Capital Management, LLC | 17.2% |
| Schedule 13G, 2026-08-14 | Ikarian Capital, LLC | 4.2% |
| Schedule 13D, 2026-06-10 | Vivo Opportunity Fund Holdings, L.P. | 21.7% |
| Schedule 13G, 2026-06-05 | Adar1 Capital Management, LLC | 24.1% |
| Schedule 13G, 2026-05-27 | Squadron Master Fund LP | 9.8% |
| Schedule 13G, 2026-01-20 | Sabby Management, LLC | 9.9% |
Money raised
| Filed | Sold | Offered |
|---|---|---|
| Form D, 2022-12-06 | $6M | $6M |
Latest IPO step: InMed Pharmaceuticals Inc. amended its IPO registration (S-1/A, 2025-08-01).
IPO filings: S-1/A, 2025-08-01, S-1, 2025-07-09, S-1/A, 2024-12-30, S-1, 2024-12-23; ticker INM on Nasdaq Capital Market.
Red flags found
1 exit or restructuring plan on Form 8-K (latest Form 8-K, 2026-03-06).
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
Permanent URL:
https://mentionfox.com/who-owns/inmed-pharmaceuticalsLast updated 2026-10-18
Primary record: Schedule 13G/A, 2026-10-07 · Form D, 2022-12-06 · S-1/A, 2025-08-01 · S-1, 2025-07-09
Who owns InMed Pharmaceuticals Inc.? Owners, funding and legal record. MentionFox, 2026-10-18. https://mentionfox.com/who-owns/inmed-pharmaceuticals